March 10, 2010 05:02 PM EDT

Eprotirome further decreased atherogenic lipoproteins in statin-treated patients

The thyroid hormone analogue eprotirome was associated with further reductions in LDL, lipoprotein A, apolipoprotein B and triglyceride levels in patients treated with statins, according to new results of a 12-week...

FULL STORY

Calendar
March 14, 2010

ACC Annual Meeting

Atlanta, ga United States of America

more information »

Quote of the day

"The whole issue of hypogonadism as a consequence of cancer treatment has been overlooked..."

Click here to read full entry. »

Featured Story

Experts stress need for full history when evaluating childhood cancer survivors for endocrine consequences

Advances in cancer therapy and treatment have resulted in increased survival rates for children with cancer — nearly 80% of children diagnosed with cancer are alive at least five years after diagnosis, according to the National Cancer Institute. However, significant survival benefits are also associated with short- and long-term morbidity later in life, and many of these are consequences of disturbances in the endocrine system. Data published in the January issue of...

FULL STORY

Endocrine Today by the numbers
High, Suppressed Thyroid-Stimulating Hormone Levels Linked to Adverse Outcomes
By the numbers